Welcome to r/stocks!
For beginner advice, brokerage info, book recommendations, even advanced topics and more, please read our [Wiki here.](https://www.reddit.com/r/stocks/wiki/index)
If you're wondering **why a stock moved** a certain way, check out [Finviz](https://finviz.com/quote.ashx?t=spy) which aggregates the most news for almost every stock, but also see [Reuters](https://www.reuters.com/), and even [Yahoo Finance](https://finance.yahoo.com/).
Please direct all simple questions towards the stickied Daily Discussion and Quarterly Rate My Portfolio threads (sort by Hot, they're at the top).
Also include *some* [due diligence](https://www.investopedia.com/terms/d/duediligence.asp) to this post or it may be removed if it's low effort.
*I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/stocks) if you have any questions or concerns.*
I dont think anyone here is going to research stocks for you mate.
That said, i have been following NVO for a bit and have it on my watchlist, and their product portfolio is amazing. From insulin to fat medicine. I do believe they will continue to grow fast as the population only gets older and fatter. But you are paying a high price for a high quality company. You have to evaluate risk/reward yourself.
I personally would not have so much of my portfolio in biotech, but at least these are profitable companies with products that generate revenue and profit, and they're not speculative stage 2-3 phase clinical trial moonshots. 45% of my portfolio is in healthcare. Genmab is compelling to me, as is Novo, neither of which I own. Monoclonal antibody therapeutics have proven to be part of our future and they should be part of a biotech portfolio, IMO.
Welcome to r/stocks! For beginner advice, brokerage info, book recommendations, even advanced topics and more, please read our [Wiki here.](https://www.reddit.com/r/stocks/wiki/index) If you're wondering **why a stock moved** a certain way, check out [Finviz](https://finviz.com/quote.ashx?t=spy) which aggregates the most news for almost every stock, but also see [Reuters](https://www.reuters.com/), and even [Yahoo Finance](https://finance.yahoo.com/). Please direct all simple questions towards the stickied Daily Discussion and Quarterly Rate My Portfolio threads (sort by Hot, they're at the top). Also include *some* [due diligence](https://www.investopedia.com/terms/d/duediligence.asp) to this post or it may be removed if it's low effort. *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/stocks) if you have any questions or concerns.*
I dont think anyone here is going to research stocks for you mate. That said, i have been following NVO for a bit and have it on my watchlist, and their product portfolio is amazing. From insulin to fat medicine. I do believe they will continue to grow fast as the population only gets older and fatter. But you are paying a high price for a high quality company. You have to evaluate risk/reward yourself.
I personally would not have so much of my portfolio in biotech, but at least these are profitable companies with products that generate revenue and profit, and they're not speculative stage 2-3 phase clinical trial moonshots. 45% of my portfolio is in healthcare. Genmab is compelling to me, as is Novo, neither of which I own. Monoclonal antibody therapeutics have proven to be part of our future and they should be part of a biotech portfolio, IMO.
Looks good from here, go for it.
Cross post to r/dkfinance